Table 1 Baseline demographic characteristics of healthcare providers enrolled in the MiCHOICE trial and the interview sub-study
Characteristic | All participants (N = 210) | Interview Completed (N = 25) | P-value |
|---|---|---|---|
Age, years (median [IQR]) | 46 [38, 53] | 46 [43, 55] | 0.40 |
Female, N (%) | 163 (77.6) | 21 (84.0) | 0.64 |
Non-Hispanic, N (%) | 196 (93.3) | 22 (88%) | 0.81 |
Race, N (%) | Â | Â | 0.47 |
Asian | 39 (19.2) | 4 (16.0) | Â |
Black/African American | 13 (6.4) | 1 (4.0) | Â |
Multiracial | 5 (2.5) | 2 (8.0) | Â |
White | 146 (71.9) | 18 (72.0) | Â |
Provider Type, N (%) | Â | Â | 0.77 |
APP | 50 (23.9) | 7 (28.0) | Â |
Physician | 156 (74.6) | 18 (72.0) | Â |
RN | 3 (1.4) | 0 (0.0) | Â |
Specialty, N (%) | Â | Â | 0.44 |
Family Practice | 4 (1.9) | 2 (8.0) | Â |
Internal Medicine | 14 (6.8) | 2 (8.0) | Â |
Obstetrics/Gynecology | 3 (1.4) | 0 (0.0) | Â |
Oncology | 110 (53.1) | 10 (40.0) | Â |
Other | 17 (8.2) | 3 (12.0) | Â |
Surgery | 59 (28.5) | 8 (32.0) | Â |
Years since completing training, N (%) | Â | Â | 0.64 |
 < 5 | 45 (21.4) | 3 (12.0) |  |
5–10 | 51 (24.3) | 5 (20.0) |  |
11–15 | 28 (13.3) | 6 (24.0) |  |
16–20 | 33 (15.7) | 4 (16.0) |  |
 > 20 | 50 (23.8) | 7 (28.0) |  |
Have not yet completed training | 3 (1.4) | 0 (0.0) | Â |
Prior use of BC risk assessment tool, N (%) | 195 (92.9) | 25 (100.0) | 0.34 |
Prescribed CP, N (%) | 174 (82.9) | 24 (96.0) | 0.16 |
Prescribed low-dose tamoxifen for CP, N (%) | 85 (71.4) | 4 (16.0) | 0.38 |
Willingness to try new technology, mean (SD) | 82.14 (17.49) | 81.32 (16.86) | 0.82 |
Confidence in knowledge of medical statistics, mean (SD) | 4.43 (0.95) | 4.64 (0.76) | 0.28 |
Confidence communicating medical statistics, mean (SD) | 4.64 (0.93) | 4.88 (0.73) | 0.21 |
Ability to help patient understand risk, mean (SD) | 4.73 (0.89) | 5.08 (0.57) | 0.05 |